Dale Mitchell is currently a Senior Director within small molecule drug discovery at Charles River. Dale has worked for Charles River and legacy companies since 2000 and has 35 years’ experience in the pharmaceutical and agrochemical industries. Dale has led a wide range of collaborative programs in areas such as inflammation, oncology, anti-infectives, neurodegeneration and PET imaging. In his current role, Dale provides strategic oversight on integrated drug discovery programs, working closely with multi-disciplinary project teams and partners to generate hit compounds, deliver lead series and identify pre-clinical candidates.